VC-backed Gritstone Oncology recruits Bellemin as EVP of finance and CFO
Emeryville, California-based Gritstone Oncology, a personalized cancer immunotherapy company, has named Jean-Marc Bellemin as executive vice president of finance and chief financial officer. His appointment became effective January 5, 2018. Previously, Bellemin worked at Actelion Pharmaceuticals USA where he served as senior vice president and chief financial officer. Gritstone Oncology's backers include Versant Ventures, The Column Group, Clarus Funds, Frazier Healthcare Partners, RedMile, Casdin Capital, Lilly Asia Ventures, Trinitas Capital, GV, Alexandria Venture Investments and Bay City Capital.
23 January 2018•3 mins read
